• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

作者信息

Gong Zimu, Zheng Lan, Tang Zhenya, Chen Zi, Wang Wei, Bai Shi, Tang Guilin, Medeiros L Jeffrey, Hu Shimin

机构信息

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Ann Hematol. 2017 Jul;96(7):1239. doi: 10.1007/s00277-017-3025-7.

DOI:10.1007/s00277-017-3025-7
PMID:28526956
Abstract
摘要

相似文献

1
Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.《酪氨酸激酶抑制剂治疗时代费城染色体变异复杂性在慢性髓性白血病中的作用》勘误
Ann Hematol. 2017 Jul;96(7):1239. doi: 10.1007/s00277-017-3025-7.
2
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.酪氨酸激酶抑制剂治疗时代变异型费城染色体复杂性在慢性髓性白血病中的作用
Ann Hematol. 2017 Mar;96(3):501-504. doi: 10.1007/s00277-016-2892-7. Epub 2016 Dec 3.
3
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
4
Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.波纳替尼用于治疗慢性髓性白血病和费城染色体阳性急性淋巴细胞白血病。
Drugs Today (Barc). 2013 Apr;49(4):261-9. doi: 10.1358/dot.2013.49.4.1950147.
5
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.BCR-ABL酪氨酸激酶特异性抑制剂在伴有费城染色体的慢性髓性白血病急变期和急性淋巴细胞白血病中的活性
N Engl J Med. 2001 Apr 5;344(14):1038-42. doi: 10.1056/NEJM200104053441402.
6
The Impact of Variant Philadelphia Chromosome Translocations on the Clinical Course of Chronic Myeloid Leukemia.变异型费城染色体易位对慢性髓性白血病临床病程的影响
Turk J Haematol. 2016 Mar 5;33(1):60-5. doi: 10.4274/tjh.2015.0237.
7
Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.费城染色体阳性白血病异基因造血干细胞移植的回顾性研究：古斯塔夫·鲁西癌症中心25年经验
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S129-40. doi: 10.1016/j.clml.2015.05.001.
8
Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.普纳替尼：一种新型酪氨酸激酶抑制剂，用于治疗慢性髓性白血病和费城染色体阳性急性淋巴细胞白血病。
Ann Pharmacother. 2013 Nov;47(11):1540-6. doi: 10.1177/1060028013501144. Epub 2013 Nov 21.
9
Signal Transduction by the Philadelphia Chromosome-encoded BCR/ABL Oncoproteins: Therapeutic Implications for Chronic Myeloid Leukemia and Philadelphia-positive Acute Lymphoblastic Leukemia.
Hematology. 1998;3(5):387-96. doi: 10.1080/10245332.1998.11746413.
10
The Philadelphia chromosome in leukemogenesis.白血病发生中的费城染色体。
Chin J Cancer. 2016 May 27;35:48. doi: 10.1186/s40880-016-0108-0.

引用本文的文献

1
Adult Ph-positive acute lymphoblastic leukemia-current concepts in cytogenetic abnormalities and outcomes.成人Ph阳性急性淋巴细胞白血病——细胞遗传学异常及预后的当前概念
Am J Cancer Res. 2020 Aug 1;10(8):2309-2318. eCollection 2020.